Coronavirus Infections
Conditions
Interventions
Non-randomized, controlled, open and blind clinical trial, where the participants will be divided into intervention groups (outpatient intervention) and control (group educational) according to the pa
E02.779.483
G11.427.410.698.277
Sponsors
Universidade Federal de Santa Catarina
Universidade Federal de Santa Catarina
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Subjects over 18 years of age diagnosed with COVID-19 in the last six months; with at least one of the following symptoms, shortness of breath, tiredness, muscle pain, joint pain and cough.
Exclusion criteria
Exclusion criteria: Patients with previous respiratory diseases such as asthma, chronic obstructive pulmonary disease, or pulmonary fibrosis; Patients with NYHA III or IV heart disease; Patients with neurological or osteoarticular diseases that limit participation in the study; Patients with difficulty understanding to perform the study tests; Patients with symptoms and cardiac alterations that contraindicate physical exertion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: It is expected to find an increase in exercise capacity, verified through an increase in the distance covered in the Incremental Shuttle Walk Test, between the pre- and post-intervention periods.;Observed Outcome 1: A significant average increase of 100.8 meters was observed for the group that received face-to-face rehabilitation (p less than 0.0001) and an average increase of 65.9 meters for the remote monitoring group (p equal to 0.001), between the pre- and post-intervention periods. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected Outcome 2: A reduction in dyspnea and fatigue symptoms is expected through a reduction in the Modified Pulmonary Functional Status Dyspnea Questionnaire score between the pre- and post-intervention periods.;Observed Outcome 2: A significant reduction in dyspnea was observed only for the face-to-face rehabilitation group through the reduction of the Modified Pulmonary Functional Status Dyspnea Questionnaire score with a median score of 8 points to 1 (p equal to 0.001), between the pre and post periods -intervention. Fatigue was significantly reduced for the face-to-face rehabilitation group by reducing the Modified Pulmonary Functional Status Dyspnea Questionnaire score with a median of 18 points to 1.5 points (p equal to 0.0001) and for the remote monitoring group with a median of 18 to 2 points (p equal to 0.012), between the pre- and post-intervention periods. | — |
Countries
Brazil
Contacts
Public ContactAderbal Aguiar
Universidade Federal de Santa Catarina
Outcome results
None listed